secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kronos Bio, Inc. (—)
CIK:        0001741830
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0001140361-23-051135
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 2.05, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Kronos Bio cuts 19% of workforce; expects ~$1.8M severance charges in Q4 2023
-----------------------------------------------------------------------------

- Board approved ~19% workforce reduction; completion expected November 2, 2023.
- Pre-tax cash severance charges of ~$1.8M in Q4 2023; up to ~$0.3M for COBRA over six months.
- After restructuring, existing resources expected to fund planned operations into 2026.
- Reduction part of strategic resource allocation and cost containment plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1741830/000114036123051135/0001140361-23-051135-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1741830/000114036123051135/ef20013915_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-051135

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer